Determinants of Medication Adherence to Antihypertensive Medications among a Chinese Population Using Morisky Medication Adherence Scale

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Lee, Gabrielle K Y ^a   Wang, Harry H X ^a   Liu, Kirin Q L ^a   Cheung, Yu ^b   Morisky, Donald E ^c   Wong, Martin C S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b HOSPITAL AUTHORITY   (Hong Kong)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEALTH CARE POLICY; HEALTH STATUS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MORISKY MEDICATION ADHERENCE SCALE; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT MONITORING; PRESCRIPTION; QUESTIONNAIRE; RATING SCALE; RISK ASSESSMENT; SELF REPORT; SOCIAL STATUS; TREATMENT DURATION; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; MEDICATION COMPLIANCE; MIDDLE AGED; STATISTICS AND NUMERICAL DATA;

AGED; ANTIHYPERTENSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYPERTENSION; MALE; MEDICATION ADHERENCE; MIDDLE AGED;

EID: 84876741517     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062775     Document Type: Article

References (48)

1. Haynes RB, Sackett DL (1976) Compliance with therapeutic regimens: Johns Hopkins University Press.
2. Sabate E, World Health Organization, WHO Adherence to Long Term Therapies Project, Global Adherence Interdisciplinary Network (2003) Adherence to long-term therapies: evidence for action. Geneva: World Health Organization. xv, 198 p.
3. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, et al. (2004) Global burden of hypertension: analysis of worldwide data. Lancet 365: 217-223.
4. Organization WHOWH (2002) The World Health Report 2002: Reducing Risks, Promoting Healthy Life: Stylus Pub Llc.
5. Lenfant C, Chobanian AV, Jones DW, Roccella EJ, (2003) Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7)- Resetting the hypertension sails (Reprinted from Hypertension, vol 41, pg 1178-1179, 2003). Circulation 107: 2993-2994.
6. Turnbull F, Neal B, Algert C, Chalmers J, Woodward M, et al. (2003) Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 362: 1527-1535.
7. Cushman WC, Ford CE, Cutler JA, Margolis KL, Davis BR, et al. (2002) Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) 4: 393-404.
8. Black HR, Elliott WJ, Neaton JD, Grandits G, Grambsch P, et al. (2001) Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial. Hypertension 37: 12-18.
9. Sabaté E, Organization ESWH (2003) Adherence to Long-Term Therapies: Evidence for Action: Stylus Pub Llc.
10. Burnier M, (2006) Medication adherence and persistence as the cornerstone of effective anti hypertensive therapy. American Journal of Hypertension 19: 1190-1196.
11. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, et al. (2004) Hypertension treatment and control in five European Countries, Canada, and the United States. Hypertension 43: 10-17.
12. Haynes RB, McDonald HP, Garg AX, (2002) Helping patients follow prescribed treatment- Clinical applications. Jama-Journal of the American Medical Association 288: 2880-2883.
13. McDonnell PJ, Jacobs MR, (2002) Hospital admissions resulting from preventable adverse drug reactions. Annals of Pharmacotherapy 36: 1331-1336.
14. Levy G, Zamacona MK, Jusko WJ, (2000) Developing compliance instructions for drug labeling. Clinical Pharmacology & Therapeutics 68: 586-591.
15. Ogden LG, He JA, Lydick E, Whelton PK, (2000) Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension 35: 539-543.
16. Osterberg L, Blaschke T, (2005) Drug therapy: Adherence to medication. New England Journal of Medicine 353: 487-497.
17. Krousel-Wood M, Thomas S, Muntner P, Morisky D, (2004) Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Current Opinion in Cardiology 19: 357-362.
18. Friedman O, McAlister FA, Yun LS, Campbell NRC, Tu K, et al. (2010) Antihypertensive Drug Persistence and Compliance Among Newly Treated Elderly Hypertensives in Ontario. American Journal of Medicine 123: 173-181.
19. Esposti LD, Saragoni S, Benemei S, Batacchi P, Geppetti P, et al. (2011) Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients. ClinicoEconomics and outcomes research: CEOR 3: 47-54.
20. Inkster ME, Donnan PT, MacDonald TM, Sullivan FM, Fahey T, (2006) Adherence to antihypertensive medication and association with patient and practice factors. Journal of Human Hypertension 20: 295-297.
21. Wang PS, Bohn RL, Knight E, Glynn RJ, Mogun H, et al. (2002) Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. Journal of General Internal Medicine 17: 504-511.
22. Yiannakopoulou E, Papadopulos JS, Cokkinos DV, Mountokalakis TD, (2005) Adherence to antihypertensive treatment: a critical factor for blood pressure control. Eur J Cardiovasc Prev Rehabil 12: 243-249.
23. Ho PM, Bryson CL, Rumsfeld JS, (2009) Medication Adherence Its Importance in Cardiovascular Outcomes. Circulation 119: 3028-3035.
24. Champion VL, (1984) Instrument development for health belief model constructs. ANS Adv Nurs Sci 6: 73-85.
25. Krousel-Wood MA, Muntner P, Islam T, Morisky DE, Webber LS (2009) Barriers to and Determinants of Medication Adherence in Hypertension Management: Perspective of the Cohort Study of Medication Adherence Among Older Adults. Medical Clinics of North America 93: 753-+.
26. Morisky DE, Ang A, Krousel-Wood M, Ward HJ, (2008) Predictive Validity of a Medication Adherence Measure in an Outpatient Setting. Journal of Clinical Hypertension 10: 348-354.
27. Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, et al. (2009) New medication adherence scale versus pharmacy fill rates in seniors with hypertension. American Journal of Managed Care 15: 59-66.
28. Zhang SY, Bai LQ, Tan HZ, Yang HL, (2010) Application of the morisky medication adherence scale on pulmonary tuberculosis patients. Chinese Journal of Antituberculosis 32: 527-530.
29. Morisky DE, DiMatteo MR, (2011) Improving the measurement of self-reported medication nonadherence: Final response. Journal of Clinical Epidemiology 64: 262-263.
30. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, et al. (2007) 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 28: 1462-1536.
31. Hyre AD, Krousel-Wood MA, Muntner P, Kawasaki L, DeSalvo KB, (2007) Prevalence and predictors of poor antihypertensive medication adherence in an urban health clinic setting. J Clin Hypertens (Greenwich) 9: 179-186.
32. Wetzels GEC, Nelemans P, Schouten JS, Prins MH, (2004) Facts and fiction of poor compliance as a cause of inadequate blood pressure control: a systematic review. Journal of Hypertension 22: 1849-1855.
33. Gerth WC, (2002) Compliance and persistence with newer antihypertensive agents. Current Hypertension Reports 4: 424-433.
34. Billups SJ, Malone DC, Carter BL, (2000) The relationship between drug therapy noncompliance and patient characteristics, health-related quality of life, and health care costs. Pharmacotherapy 20: 941-949.
35. Morris AB, Li J, Kroenke K, Bruner-England TE, Young JM, et al. (2006) Factors associated with drug adherence and blood pressure control in patients with hypertension. Pharmacotherapy 26: 483-492.
36. Lam P, Lum C, Leung M, (2007) Drug non-adherence and associated risk factors among Chinese geriatric patients in Hong Kong. Hong Kong Medical Journal 13: 284.
37. Elliott WJ, Plauschinat CA, Skrepnek GH, Gause D, (2007) Persistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapies. The Journal of the American Board of Family Medicine 20: 72-80.
38. Wong MC, Jiang JY, Griffiths SM, (2010) Factors associated with antihypertensive drug compliance in 83,884 Chinese patients: a cohort study. J Epidemiol Community Health 64: 895-901.
39. Wong MCS, Jiang JY, Griffiths SM, (2011) Factors associated with compliance to thiazide diuretics among 8551 Chinese patients. Journal of Clinical Pharmacy and Therapeutics 36: 179-186.
40. Wong MCS, Jiang JY, Griffiths SM, (2009) Short-Term Adherence to beta-Blocker Therapy Among Ethnic Chinese Patients With Hypertension: A Cohort Study. Clinical Therapeutics 31: 2170-2177.
41. Wong MCS, Jiang JY, Griffiths SM, (2010) Antihypertensive Drug Adherence Among 6408 Chinese Patients on Angiotensin-Converting Enzyme Inhibitors in Hong Kong: A Cohort Study. Journal of Clinical Pharmacology 50: 598-605.
42. Wong MCS, Jiang JY, Griffiths SM, (2009) Factors Associated With Compliance, Discontinuation and Switching of Calcium Channel Blockers in 20,156 Chinese Patients. American Journal of Hypertension 22: 904-910.
43. Degli Esposti E, Sturani A, Di Martino M, Falasca P, Novi MV, et al. (2002) Long-term persistence with antihypertensive drugs in new patients. Journal of Human Hypertension 16: 439-444.
44. Carter BL (2007) Adherence, Quality of Life, Cost Effectiveness, and the Role of the Pharmacist. In: Lip GYH, Hall JE, editors. Comprehensive hypertension Philadelphia: Mosby Elsevier. 1119-1127.
45. Jackevicius CA, Mamdami M, Tu JV, (2002) Adherence with statin therapy in elderly patients with and without acute coronary syndromes. Jama-Journal of the American Medical Association 288: 462-467.
46. Svensson S, Kjellgren KI, Ahlner J, Saljo R, (2000) Reasons for adherence with antihypertensive medication. International Journal of Cardiology 76: 157-163.
47. Zyczynski TM, Coyne KS, (2000) Hypertension and current issues in compliance and patient outcomes. Current Hypertension Reports 2: 510-514.
48. Jin J, Sklar GE, Min Sen Oh V, Chuen Li S, (2008) Factors affecting therapeutic compliance: A review from the patient's perspective. Ther Clin Risk Manag 4: 269-286.